C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2011
11/29/2011	US8067540 Human ALEX1 proteins
11/29/2011	US8067539 g-protein coupled receptor used in identifying modulators which improve palatability of low-calorie beverages through development of new artificial sweeteners; modulating taste perception
11/29/2011	US8067538 Gene related to growth promoting function of acetic acid bacterium, acetic acid bacterium bred using the gene and method for producing vinegar using the acetic acid bacterium
11/29/2011	US8067535 Identification of gene sequences and proteins involved in vaccinia virus dominant T cell epitopes
11/29/2011	US8067377 Peptide compositions for targeting adipose tissue
11/29/2011	US8067375 Treatment of demyelinating disorders with soluble lymphotoxin-β-receptor
11/29/2011	US8067373 Therapeutic fibrin-derived peptides and uses thereof
11/29/2011	US8067372 Modulation of angiogenesis by A-beta peptide fragments
11/29/2011	US8067368 Vascular endothelial growth factors and methods of their use
11/29/2011	US8067367 Methods of increasing platelet and hematopoietic stem cell production
11/29/2011	US8067366 Facilitation of resuscitation from cardiac arrest by erythropoietin
11/29/2011	US8067364 Deer antler extract for promoting angiogenesis
11/29/2011	US8067362 Antidiabetic agents; genetic engineered polypeptide; having a side chain attached alpha -amino group of the N-terminal amino acid of the B chain via an amide bond, with free carboxylic acid group, a fatty acid; soluble at physiological pH, prolonged profile of action; hypoglycemic agents
11/29/2011	US8067361 Chaperonin 10 immunosuppression
11/29/2011	US8067360 Method for promoting bone growth using activin-ActRIIa antagonists
11/29/2011	US8067357 Annexin derivatives suitable for pretargeting in therapy and diagnosis
11/29/2011	US8067236 Optimized human T1R3 nucleic acid molecule
11/29/2011	US8067235 Optimized human T1R2 nucleic acid molecule
11/29/2011	US8067231 Clostridial toxin activity assays
11/29/2011	US8067229 Ucp4
11/29/2011	US8067228 Nucleic acid compositions and their use against the hepatitic C virus
11/29/2011	US8067227 Viral vectors and the use of the same for gene therapy
11/29/2011	US8067224 Presenilin associated membrane protein (PAMP) and uses thereof
11/29/2011	US8067219 Polynucleotide encoding an ATP binding cassette transporter 1 (ABC1) polypeptide
11/29/2011	US8067210 Method of producing lysine by culturing a host cell expressing a polynucleotide encoding a feedback resistant aspartokinase from corynebacterium
11/29/2011	US8067202 Bacterial superantigen vaccines
11/29/2011	US8067200 Fusion proteins
11/29/2011	US8067198 Protein expression system
11/29/2011	US8067197 Soluble recombinant αvβ3 adhesion receptor
11/29/2011	US8067185 Methods of quantifying taste of compounds for food or beverages
11/29/2011	US8067182 Method of weak partitioning chromatography
11/29/2011	US8067172 Device, kit and method for pulsing biological samples with an agent and stabilising the sample so pulsed
11/29/2011	US8067021 Methods and compositions for delivery of growth factor to fibrous connective tissue
11/29/2011	US8067016 Fusion proteins of Mycobacterium tuberculosis
11/29/2011	US8067015 Delivery device for topical, oral, intravenous, intraperitoneal, intramuscular, transdermal, nasal, or iontophoretic administration coated with a RNAIII inhibiting heptapeptide of the sequence Tyr-X2-Pro-X1-Thr-Asn-Phe where X1 is Cys, Trp or Ile, and X2 is Lys or Ser; antibiotic resistance
11/29/2011	US8067011 Compositions and methods for treating B-cell malignancies
11/29/2011	US8067010 Immunological herpes simplex virus antigens and methods for use thereof
11/29/2011	US8067004 Surface antigen
11/29/2011	US8067000 Cancer treatment with endothelin receptor antagonists
11/29/2011	US8066997 Modulation of activity of neurotrophins
11/29/2011	US8066994 Proteins comprising an IgG2 domain
11/29/2011	US8066991 Enzyme inhibitors of PAI-1
11/29/2011	US8066981 Compositions and methods related to toll-like receptor-3
11/29/2011	CA2662024C Thermostablization of dna polymerase by protein folding pathway from a hyperthermophile archaeon, pyrococcus furiosus
11/29/2011	CA2638985C Therapeutic agent containing .omega.-feline interferon for treating feline atopic dermatitis
11/29/2011	CA2490098C Plant defensins
11/29/2011	CA2484166C Improved chimeric glycoproteins and pseudotyped lentiviral vectors
11/29/2011	CA2448208C Influenza vaccine composition
11/29/2011	CA2442909C Multimerization of hiv-1 vif protein as a therapeutic target
11/29/2011	CA2440461C Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
11/29/2011	CA2414331C Pd-l2 molecules: novel pd-1 ligands and uses therefor
11/29/2011	CA2401438C Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
11/29/2011	CA2293632C Artificial antibody polypeptides
11/29/2011	CA2233447C Mimicking peptides in cancer therapy
11/29/2011	CA2232626C Novel affinity ligands and their use
11/27/2011	CA2752943A1 A method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof
11/24/2011	WO2011146891A2 High-affinity fully functional soluble single-domain human cd4, antibodies, and related fusion proteins
11/24/2011	WO2011146715A1 Compositions and methods for the delivery of therapeutic peptides
11/24/2011	WO2011146704A1 Degradable clostridial toxins
11/24/2011	WO2011146480A1 Biglycan mutants and related therapeutics and methods of use
11/24/2011	WO2011145629A2 ANTIBODY CAPABLE OF BINDING TO TRANSFORMING GROWTH FACTOR ALPHA AND HAVING ANTIPROLIFERATIVE ACTIVITY ON CANCER HAVING Ras GENE MUTATION
11/24/2011	WO2011145013A1 Parapoxvirus vectors containing rabies virus antigen
11/24/2011	WO2011144953A1 Procedure for producing recombinant human tissue factor
11/24/2011	WO2011144751A1 Improved anti-serum albumin binding variants
11/24/2011	WO2011144606A1 Hydrophobic interaction chromatography method
11/24/2011	WO2011144360A1 Marker vaccine for classical swine fever
11/24/2011	WO2011144264A1 Method for isolating small rna-molecules using hc-pro protein
11/24/2011	WO2011143788A1 Novel glucagon like peptide analogs, composition, and method of use
11/24/2011	WO2011143702A1 Methods of crystallising perforin
11/24/2011	WO2011143701A1 Crystal structure of perforin and methods for its use as a structural model
11/24/2011	WO2011122761A3 Gsdl2 protein having a life-extension function for plants and a stress resistance function for plants, gene thereof, and use thereof
11/24/2011	WO2011120135A8 Antibodies with enhanced or suppressed effector function
11/24/2011	WO2011120134A8 Antibodies with enhanced or suppressed effector function
11/24/2011	WO2011113618A4 Immune therapy
11/24/2011	WO2011110861A3 Therapy for influenza like illness
11/24/2011	WO2011087934A3 Kexin-derived vaccines to prevent or treat fungal infections
11/24/2011	WO2011082422A3 Human immunodeficiency virus (hiv-1) highly conserved and low variant sequences as targets for vaccine and diagnostic applications
11/24/2011	WO2011075605A3 Hyperglycosylated interferon variants and methods of use
11/24/2011	WO2011063283A3 Methods for detecting a mycobacterium tuberculosis infection
11/24/2011	WO2011063198A3 Methods and compositions for modulating the activity of the interleukin-35 receptor complex
11/24/2011	WO2011063195A3 Purification of modified cytokines
11/24/2011	WO2011043814A3 Fluorescent proteins and uses thereof
11/24/2011	WO2010142461A3 Treatment of coagulopathy with hyperfibrinolysis
11/24/2011	US20110289627 Modified cry3a toxins and nucleic acid sequences coding therefor
11/24/2011	US20110289623 Compositions and methods for the modification of gene expression
11/24/2011	US20110289622 Expression cassettes for transgenic expression of nucleic acids
11/24/2011	US20110289621 Non-transgenic Tomato Varieties Having Increased Shelf Life Post-harvest
11/24/2011	US20110289619 Rice brown planthopper resistance gene and applications thereof
11/24/2011	US20110289616 Soybean Cultivar S080093
11/24/2011	US20110289615 Soybean Cultivar 8919112
11/24/2011	US20110289614 Soybean Cultivar S090018
11/24/2011	US20110289613 Soybean Cultivar S090020
11/24/2011	US20110289612 Soybean Cultivar S090012
11/24/2011	US20110289610 Hcv/gbv-b chimeric virus
11/24/2011	US20110289609 Neurotransmitter Sensors and Methods of Using the Same
11/24/2011	US20110289604 Methods for Identifying Modulating Compounds of Lymphangiogenesis, Means Therefore, Compounds and Uses Thereof
11/24/2011	US20110288275 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/24/2011	US20110288274 Designer collagens and use thereof
11/24/2011	US20110288272 Modified cry3a toxins and nucleic acid sequences coding therefor
11/24/2011	US20110288269 Design of Spacers To Increase The Expression of Recombinant Fusion Proteins

1 ... 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 ... 2916